Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $0.76 to $0.55 vs $0.76 Est; Lowers FY2026 Sales Guidance from $910.000M to $900.000M vs $908.995M Est
Benzinga Newsdesk 4 hours ago
NewsGuidance
Usana Health Sciences (NYSE:USNA) lowers FY2026 Adj EPS guidance from $0.76 to $0.55 vs $0.76 analyst estimate. Lowers FY2026 sales outlook from $910.000 million to $900.000 million vs $908.995 million estimate.
Usana Health Sciences (NYSE:USNA) lowers FY2026 Adj EPS guidance from $0.76 to $0.55 vs $0.76 analyst estimate. Lowers FY2026 sales outlook from $910.000 million to $900.000 million vs $908.995 million estimate.